Complement, viruses, and virus-infected cells - PubMed (original) (raw)

Review

Complement, viruses, and virus-infected cells

N R Cooper et al. Springer Semin Immunopathol. 1983.

Abstract

The attachment of specific antibody to viral glycoproteins and other structures on the surface of a virus or virus-infected cell has a number of potential consequences to the virus or virus-infected cell. Antibody is multivalent and thus able to redistribute or patch surface viral proteins or virus-encoded structures within the lipid bilayer of the viral envelope or the cell membrane. In certain instances, antibody may agglutinate viruses or virus-infected cells. The physical presence of antibody molecules on the virus surface may interfere with the ability of the virus to infect potentially susceptible cells. Antibody on the surface of virus-infected cells may prevent the maturation and release of virus particles; antibody also can alter certain normal cell functions. The Fc portions of antibody molecules bound to virus-infected cells facilitate interactions with effector cells bearing Fc receptors. In the case of lymphocytes and perhaps phagocytic cells, this interaction may lead to antibody-dependent cellular cytotoxicity (ADCC) [51, 58]. The exposed Fc regions may also facilitate attempts at ingestion by monocytes, macrophages, and polymorphonuclear leukocytes.

PubMed Disclaimer

Similar articles

• The complement system: its importance in the host response to viral infection.
  Hirsch RL. Hirsch RL. Microbiol Rev. 1982 Mar;46(1):71-85. doi: 10.1128/mr.46.1.71-85.1982. Microbiol Rev. 1982. PMID: 7045625 Free PMC article. Review. No abstract available.
• The role of antibody and complement in lysing virus-infected cells.
  Sissons JG, Schreiber RD, Cooper NR, Oldstone MB. Sissons JG, et al. Med Microbiol Immunol. 1982;170(4):221-7. doi: 10.1007/BF02123312. Med Microbiol Immunol. 1982. PMID: 7048046 Review. No abstract available.
• [Immunity of viruses and the effectiveness of vaccines. Mechanism of protective immune response of hosts to viruses].
  Shimizu K. Shimizu K. Nihon Rinsho. 1987 Oct;45(10):2211-7. Nihon Rinsho. 1987. PMID: 2452259 Japanese. No abstract available.
• The role of antibody and complement in the control of viral infections.
  Cooper NR, Nemerow GR. Cooper NR, et al. J Invest Dermatol. 1984 Jul;83(1 Suppl):121s-127s. doi: 10.1111/1523-1747.ep12281847. J Invest Dermatol. 1984. PMID: 6376646 Review.
• Virus-Encoded Complement Regulators: Current Status.
  Sinha A, Singh AK, Kadni TS, Mullick J, Sahu A. Sinha A, et al. Viruses. 2021 Jan 29;13(2):208. doi: 10.3390/v13020208. Viruses. 2021. PMID: 33573085 Free PMC article. Review.

Cited by

• Idiopathic membranoproliferative glomerulonephritis in childhood.
  West CD. West CD. Pediatr Nephrol. 1992 Jan;6(1):96-103. doi: 10.1007/BF00856851. Pediatr Nephrol. 1992. PMID: 1536750 Review.
• Antibody bivalency improves antiviral efficacy by inhibiting virion release independently of Fc gamma receptors.
  Sahin M, Remy MM, Fallet B, Sommerstein R, Florova M, Langner A, Klausz K, Straub T, Kreutzfeldt M, Wagner I, Schmidt CT, Malinge P, Magistrelli G, Izui S, Pircher H, Verbeek JS, Merkler D, Peipp M, Pinschewer DD. Sahin M, et al. Cell Rep. 2022 Feb 1;38(5):110303. doi: 10.1016/j.celrep.2022.110303. Cell Rep. 2022. PMID: 35108544 Free PMC article.
• Species selective interaction of Alphaherpesvirinae with the "unspecific" immune system of the host.
  Huemer HP, Larcher C, van Drunen Littel-van den Hurk S, Babiuk LA. Huemer HP, et al. Arch Virol. 1993;130(3-4):353-64. doi: 10.1007/BF01309666. Arch Virol. 1993. PMID: 8390825
• Target recognition failure by the nonspecific defense system: surface constituents of pathogens interfere with the alternative pathway of complement activation.
  Horstmann RD. Horstmann RD. Infect Immun. 1992 Mar;60(3):721-7. doi: 10.1128/iai.60.3.721-727.1992. Infect Immun. 1992. PMID: 1541544 Free PMC article. Review. No abstract available.
• Coagulation factor defends adenovirus from immune attack.
  Nemerow GR. Nemerow GR. Nat Med. 2013 Apr;19(4):406-7. doi: 10.1038/nm.3149. Nat Med. 2013. PMID: 23558626 No abstract available.

References

1. 1. Almeida JD, Waterson AP. The morphology of virus antibody interaction. Adv Virus Res. 1969;15:307. - PMC - PubMed
2. 1. Almeida JD, Cinader B, Howatson A. The structure of antigen-antibody complexes: A study by electron microscopy. J Exp Med. 1963;118:327. - PMC - PubMed
3. 1. Apostolov K, Sawa MI. Enhancement of hemolysis by Newcastle disease virus after pretreatment with heterophil antibody and complement. J Gen Virol. 1976;33:459. - PubMed
4. 1. Bartholomew RM, Esser AF, Müller-Eberhard HJ. Lysis of oncornaviruses by human serum: Isolation of the viral complement (C1) receptor and identification as p15E. J Exp Med. 1978;147:844. - PMC - PubMed
5. 1. Beebe DP, Cooper NR. Neutralization of vesicular stomatitis virus (VSV) by human complement requires a natural IgM antibody present in human serum. J Immunol. 1981;126:1562. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • PubMed Central

• Medical

  • MedlinePlus Health Information